Senti Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +42.2% | +51.6% | +30.2% | +38.5% | +7.8% | -37.8% | |
| – | +32.7% | +743.8% | +614.2% | -41.0% | -81.9% | +225.1% | |
| – | – | – | -66.8% | – | – | – | |
| – | -1,531.5% | – | +2,160.8% | -66.4% | -13.3% | -11.9% | |
| – | -41.8% | +377.4% | +646.4% | -70.9% | -99.8% | +653.8% | |
| – | +202.8% | -148.8% | +1,378.6% | – | -99.9% | -641.2% | |
| – | – | – | +132,796.8% | -92.2% | – | – | |
| – | – | – | – | +161.2% | – | – | |
| – | +0.0% | -100.2% | – | -102.1% | -100.0% | – | |
| – | +171.6% | +79.9% | +73.2% | -99.3% | +6,797.3% | -78.1% | |
| – | +335.3% | +12.0% | -94.0% | -1,370.0% | – | -357.7% | |
| – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.